Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to ...
Avalyn has initiated the AURA Phase II clinical trial assessing the efficacy and safety of AP02, inhaled nintedanib delivered ...
AURA Phase 2 clinical trial designed to evaluate the safety and efficacy of AP02 compared to placebo in patients with ...
This study investigates the association between liver fibrosis and diabetic peripheral neuropathy (DPN) in patients with type ...
FIB-4 index shows limited accuracy for individual MASLD patients. Learn more about its role and challenges in liver fibrosis ...
Reliance on FIB-4 screening tool alone may not identify some patients with significant fib ...
Using routine clinical data, the model gauges liver cancer risk better than existing tools, offering a potential way to identify high-risk patients missed by current screening criteria.
A new global review shows that countries are taking very different approaches to regulating polygenic embryo testing. For more than four decades, in vitro fertilization (IVF) has helped families have ...
The Fibrosis-4 (FIB-4) index, computed from age, aspartate aminotrasfertase (AST) and alanine aminotransferase (ALT) levels, and platelet count, was originally developed in 832 pa ...
NHANES 2017–2018 elastography data (n=4102) linked to mortality showed 59 deaths over ~24 months; decedents were older and more likely to have diabetes. MASLD (CAP ≥274 dB/m) with diabetes carried ...
Fatty liver disease is when too much fat builds up in the liver. The liver is the body's filter. It helps clean the blood, ...